{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:45:11Z","timestamp":1791931511143,"version":"4.3.4"},"publisher-location":"Berlin, Heidelberg","reference-count":104,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/164_2026_843","type":"book-chapter","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:47:46Z","timestamp":1791928066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond PROTACs: Conditional Technologies and New Frontiers"],"prefix":"10.1007","author":[{"given":"Ying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"843_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman Y et al (2021) Autophagy in healthy aging and disease. Nat Aging 1:634\u2013650. https:\/\/doi.org\/10.1038\/s43587-021-00098-4","journal-title":"Nat Aging"},{"key":"843_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1083\/jcb.124.6.903","volume":"124","author":"M Baba","year":"1994","unstructured":"Baba M, Takeshige K, Baba N, Ohsumi Y (1994) Ultrastructural analysis of the autophagic process in yeast: detection of autophagosomes and their characterization. J Cell Biol 124:903\u2013913. https:\/\/doi.org\/10.1083\/jcb.124.6.903","journal-title":"J Cell Biol"},{"key":"843_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62099-w","volume":"16","author":"K Baek","year":"2025","unstructured":"Baek K et al (2025) Unveiling the hidden interactome of CRBN molecular glues. Nat Commun 16:6831. https:\/\/doi.org\/10.1038\/s41467-025-62099-w","journal-title":"Nat Commun"},{"key":"843_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202503958","volume":"64","author":"AG Baker","year":"2025","unstructured":"Baker AG, Ho APT, Itzhaki LS, Fruk L (2025) Nanoparticle-mediated targeted protein degradation: an emerging therapeutics technology. Angew Chem Int Ed Engl 64:e202503958. https:\/\/doi.org\/10.1002\/anie.202503958","journal-title":"Angew Chem Int Ed Engl"},{"key":"843_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik SM et al (2020) Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 584:291\u2013297. https:\/\/doi.org\/10.1038\/s41586-020-2545-9","journal-title":"Nature"},{"key":"843_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"JE Bolden","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769\u2013784. https:\/\/doi.org\/10.1038\/nrd2133","journal-title":"Nat Rev Drug Discov"},{"key":"843_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202412925","volume":"63","author":"J Bonet-Aleta","year":"2024","unstructured":"Bonet-Aleta J, Maehara T, Craig BA, Bernardes GJL (2024) Small Molecule RNA Degraders. Angew Chem Int Ed Engl 63:e202412925. https:\/\/doi.org\/10.1002\/anie.202412925","journal-title":"Angew Chem Int Ed Engl"},{"key":"843_CR8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","volume":"17","author":"DF Caianiello","year":"2021","unstructured":"Caianiello DF et al (2021) Bifunctional small molecules that mediate the degradation of extracellular proteins. Nat Chem Biol 17:947\u2013953. https:\/\/doi.org\/10.1038\/s41589-021-00851-1","journal-title":"Nat Chem Biol"},{"key":"843_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1021\/acs.biochem.1c00330","volume":"62","author":"K Cassidy","year":"2023","unstructured":"Cassidy K, Zhao H (2023) Redefining the scope of targeted protein degradation: translational opportunities in hijacking the autophagy-lysosome pathway. Biochemistry 62:580\u2013587. https:\/\/doi.org\/10.1021\/acs.biochem.1c00330","journal-title":"Biochemistry"},{"key":"843_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00018-025-05883-7","volume":"82","author":"I Chavan","year":"2025","unstructured":"Chavan I, Bhattacharjee A (2025) Lysosome heterogeneity and diversity mapped through its distinct cellular functions. Cell Mol Life Sci 82:380. https:\/\/doi.org\/10.1007\/s00018-025-05883-7","journal-title":"Cell Mol Life Sci"},{"key":"843_CR11","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1021\/acschembio.1c00693","volume":"16","author":"PH Chen","year":"2021","unstructured":"Chen PH et al (2021) Modulation of phosphoprotein activity by phosphorylation targeting chimeras (PhosTACs). ACS Chem Biol 16:2808\u20132815. https:\/\/doi.org\/10.1021\/acschembio.1c00693","journal-title":"ACS Chem Biol"},{"key":"843_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/bs.mie.2022.08.014","volume":"681","author":"LY Chen","year":"2023","unstructured":"Chen LY, Wang WW, Wozniak JM, Parker CG (2023) A heterobifunctional molecule system for targeted protein acetylation in cells. Methods Enzymol 681:287\u2013323. https:\/\/doi.org\/10.1016\/bs.mie.2022.08.014","journal-title":"Methods Enzymol"},{"key":"843_CR13","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1021\/jacs.4c00826","volume":"146","author":"N Chen","year":"2024","unstructured":"Chen N et al (2024a) Sulfatase-induced in situ formulation of antineoplastic supra-PROTACs. J Am Chem Soc 146:10753\u201310766. https:\/\/doi.org\/10.1021\/jacs.4c00826","journal-title":"J Am Chem Soc"},{"key":"843_CR14","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1021\/acschembio.4c00438","volume":"19","author":"LY Chen","year":"2024","unstructured":"Chen LY et al (2024b) Functional investigations of p53 acetylation enabled by heterobifunctional molecules. ACS Chem Biol 19:1918\u20131929. https:\/\/doi.org\/10.1021\/acschembio.4c00438","journal-title":"ACS Chem Biol"},{"key":"843_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202506618","volume":"64","author":"X Chen","year":"2025","unstructured":"Chen X et al (2025) Supramolecular host-guest assemblies for tunable and modular lysosome-targeting protein degradation. Angew Chem Int Ed Engl 64:e202506618. https:\/\/doi.org\/10.1002\/anie.202506618","journal-title":"Angew Chem Int Ed Engl"},{"key":"843_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2011.01.030","volume":"152","author":"R Cheng","year":"2011","unstructured":"Cheng R et al (2011) Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Control Release 152:2\u201312. https:\/\/doi.org\/10.1016\/j.jconrel.2011.01.030","journal-title":"J Control Release"},{"key":"843_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202400682","volume":"26","author":"J Cheng","year":"2025","unstructured":"Cheng J, Dong G, Wang W, Sheng C (2025) Precise modulation of protein degradation by smart PROTACs. Chembiochem 26:e202400682. https:\/\/doi.org\/10.1002\/cbic.202400682","journal-title":"Chembiochem"},{"key":"843_CR18","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1039\/d5tb01162k","volume":"13","author":"H Cho","year":"2025","unstructured":"Cho H, Kim J, Lee H, Kang H, Kim K (2025) Nanotechnology-based strategies for overcoming clinical limitations of PROTACs in cancer therapy. J Mater Chem B 13:13206\u201313220. https:\/\/doi.org\/10.1039\/d5tb01162k","journal-title":"J Mater Chem B"},{"key":"843_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41580-018-0053-7","volume":"19","author":"PJ Cullen","year":"2018","unstructured":"Cullen PJ, Steinberg F (2018) To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nat Rev Mol Cell Biol 19:679\u2013696. https:\/\/doi.org\/10.1038\/s41580-018-0053-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"843_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1042\/bj0600604","volume":"60","author":"C De Duve","year":"1955","unstructured":"De Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F (1955) Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J 60:604\u2013617. https:\/\/doi.org\/10.1042\/bj0600604","journal-title":"Biochem J"},{"key":"843_CR21","doi-asserted-by":"publisher","first-page":"8832","DOI":"10.1039\/d2cs00624c","volume":"51","author":"Y Ding","year":"2022","unstructured":"Ding Y, Xing D, Fei Y, Lu B (2022) Emerging degrader technologies engaging lysosomal pathways. Chem Soc Rev 51:8832\u20138876. https:\/\/doi.org\/10.1039\/d2cs00624c","journal-title":"Chem Soc Rev"},{"key":"843_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202400349","volume":"9","author":"Y Fang","year":"2025","unstructured":"Fang Y et al (2025) Aptamer-RIBOTAC strategy enabling tumor-specific targeted degradation of MicroRNA for precise cancer therapy. Small Methods 9:e2400349. https:\/\/doi.org\/10.1002\/smtd.202400349","journal-title":"Small Methods"},{"key":"843_CR23","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1016\/j.apsb.2025.07.020","volume":"15","author":"Z Fu","year":"2025","unstructured":"Fu Z et al (2025) Photodynamic enhancement of PROTAC prodrug activation in hypoxic tumors. Acta Pharm Sin B 15:4945\u20134960. https:\/\/doi.org\/10.1016\/j.apsb.2025.07.020","journal-title":"Acta Pharm Sin B"},{"key":"843_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2026.115775","volume":"230","author":"Z Fu","year":"2026","unstructured":"Fu Z, Pan M, Yang C, Hou H, Li J (2026) Rational modification of PROTACs for tumor-selective protein degradation. Adv Drug Deliv Rev 230:115775. https:\/\/doi.org\/10.1016\/j.addr.2026.115775","journal-title":"Adv Drug Deliv Rev"},{"key":"843_CR25","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.scib.2023.04.028","volume":"68","author":"J Gao","year":"2023","unstructured":"Gao J et al (2023) Stimuli-activatable PROTACs for precise protein degradation and cancer therapy. Sci Bull (Beijing) 68:1069\u20131085. https:\/\/doi.org\/10.1016\/j.scib.2023.04.028","journal-title":"Sci Bull (Beijing)"},{"key":"843_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50735-w","volume":"15","author":"J Gao","year":"2024","unstructured":"Gao J et al (2024) A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy. Nat Commun 15:6608. https:\/\/doi.org\/10.1038\/s41467-024-50735-w","journal-title":"Nat Commun"},{"key":"843_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41587-024-02164-9","volume":"42","author":"K Garber","year":"2024","unstructured":"Garber K (2024) The glue degraders. Nat Biotechnol 42:546\u2013550. https:\/\/doi.org\/10.1038\/s41587-024-02164-9","journal-title":"Nat Biotechnol"},{"key":"843_CR28","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1021\/acschembio.5c00684","volume":"20","author":"Z Guo","year":"2025","unstructured":"Guo Z et al (2025) Ligand-directed self-assembling chimeras for targeted protein O-GlcNAcylation. ACS Chem Biol 20:2907\u20132916. https:\/\/doi.org\/10.1021\/acschembio.5c00684","journal-title":"ACS Chem Biol"},{"key":"843_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s43018-025-01081-3","volume":"7","author":"E Haines","year":"2026","unstructured":"Haines E et al (2026) The MEK-RAF molecular glue IK-595 has potent antitumor activity across RAS\/MAPK pathway-altered cancers. Nat Cancer 7:116\u2013130. https:\/\/doi.org\/10.1038\/s43018-025-01081-3","journal-title":"Nat Cancer"},{"key":"843_CR30","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0064","volume":"28","author":"H He","year":"2024","unstructured":"He H et al (2024) Ultrasound controllable release of proteolysis targeting chimeras for triple-negative breast cancer treatment. Biomater Res 28:0064. https:\/\/doi.org\/10.34133\/bmr.0064","journal-title":"Biomater Res"},{"key":"843_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","volume":"25","author":"M Hinterndorfer","year":"2025","unstructured":"Hinterndorfer M, Spiteri VA, Ciulli A, Winter GE (2025) Targeted protein degradation for cancer therapy. Nat Rev Cancer 25:493\u2013516. https:\/\/doi.org\/10.1038\/s41568-025-00817-8","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"843_CR32","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1021\/jacs.3c13320","volume":"146","author":"RA Howell","year":"2024","unstructured":"Howell RA, Wang S, Khambete M, McDonald DM, Spiegel DA (2024) Bifunctional molecules that induce both targeted degradation and transcytosis of extracellular proteins in brain cells. J Am Chem Soc 146(24):16404\u201316411. https:\/\/doi.org\/10.1021\/jacs.3c13320","journal-title":"J Am Chem Soc"},{"key":"843_CR33","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1021\/jacs.2c11706","volume":"145","author":"Z Hu","year":"2023","unstructured":"Hu Z et al (2023) Targeted dephosphorylation of tau by phosphorylation targeting chimeras (PhosTACs) as a therapeutic modality. J Am Chem Soc 145:4045\u20134055. https:\/\/doi.org\/10.1021\/jacs.2c11706","journal-title":"J Am Chem Soc"},{"key":"843_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118146","volume":"300","author":"TY Hu","year":"2025","unstructured":"Hu TY, Jin X, Qi ZT, Wang G, Zhen L (2025) Design, synthesis, and anti-cancer evaluation of NQO1-responsive prodrug of gemcitabine. Eur J Med Chem 300:118146. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118146","journal-title":"Eur J Med Chem"},{"key":"843_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41565-023-01562-5","volume":"19","author":"X Huang","year":"2024","unstructured":"Huang X et al (2024) Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors. Nat Nanotechnol 19:545\u2013553. https:\/\/doi.org\/10.1038\/s41565-023-01562-5","journal-title":"Nat Nanotechnol"},{"key":"843_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","volume":"638","author":"B Huang","year":"2025","unstructured":"Huang B et al (2025) Designed endocytosis-inducing proteins degrade targets and amplify signals. Nature 638:796\u2013804. https:\/\/doi.org\/10.1038\/s41586-024-07948-2","journal-title":"Nature"},{"key":"843_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T et al (2010) Identification of a primary target of thalidomide teratogenicity. Science 327:1345\u20131350. https:\/\/doi.org\/10.1126\/science.1177319","journal-title":"Science"},{"key":"843_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28520-4","volume":"13","author":"CH Ji","year":"2022","unstructured":"Ji CH et al (2022) The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system. Nat Commun 13:904. https:\/\/doi.org\/10.1038\/s41467-022-28520-4","journal-title":"Nat Commun"},{"key":"843_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202400770","volume":"20","author":"P Ji","year":"2024","unstructured":"Ji P et al (2024) Lysosome-targeting bacterial outer membrane vesicles for tumor specific degradation of PD-L1. Small 20:e2400770. https:\/\/doi.org\/10.1002\/smll.202400770","journal-title":"Small"},{"key":"843_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2026.115808","volume":"232","author":"X Jiang","year":"2026","unstructured":"Jiang X et al (2026) Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications. Adv Drug Deliv Rev 232:115808. https:\/\/doi.org\/10.1016\/j.addr.2026.115808","journal-title":"Adv Drug Deliv Rev"},{"key":"843_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189060","volume":"26","author":"MM Kasembeli","year":"2025","unstructured":"Kasembeli MM, Rodas J, Tweardy DJ (2025) Update on structure and function of SH2 domains: mechanisms and emerging targeting strategies. Int J Mol Sci 26:9060. https:\/\/doi.org\/10.3390\/ijms26189060","journal-title":"Int J Mol Sci"},{"key":"843_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chembiol.2025.12.012","volume":"33","author":"DT Ke","year":"2026","unstructured":"Ke DT, Zhan Z, Zhang W, Hu Z, Chen PH (2026) Deciphering phosphorylation TACtics: advances in phosphorylation targeting strategies and bifunctional modalities. Cell Chem Biol 33:153\u2013168. https:\/\/doi.org\/10.1016\/j.chembiol.2025.12.012","journal-title":"Cell Chem Biol"},{"key":"843_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrm2245","volume":"8","author":"DJ Klionsky","year":"2007","unstructured":"Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 8:931\u2013937. https:\/\/doi.org\/10.1038\/nrm2245","journal-title":"Nat Rev Mol Cell Biol"},{"key":"843_CR44","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acschemneuro.3c00390","volume":"14","author":"T Ko","year":"2023","unstructured":"Ko T et al (2023) Photoactivated protein degrader for optical control of synaptic function. ACS Chem Neurosci 14:3704\u20133713. https:\/\/doi.org\/10.1021\/acschemneuro.3c00390","journal-title":"ACS Chem Neurosci"},{"key":"843_CR45","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.chembiol.2024.04.002","volume":"31","author":"M Konstantinidou","year":"2024","unstructured":"Konstantinidou M, Arkin MR (2024) Molecular glues for protein-protein interactions: progressing toward a new dream. Cell Chem Biol 31:1064\u20131088. https:\/\/doi.org\/10.1016\/j.chembiol.2024.04.002","journal-title":"Cell Chem Biol"},{"key":"843_CR46","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1021\/acs.accounts.5c00441","volume":"58","author":"M Konstantinidou","year":"2025","unstructured":"Konstantinidou M, Virta JM, Arkin MR (2025) Stabilization of native protein-protein interactions with molecular glues: a 14-3-3 case study. Acc Chem Res 58:2840\u20132851. https:\/\/doi.org\/10.1021\/acs.accounts.5c00441","journal-title":"Acc Chem Res"},{"key":"843_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1042\/ebc20253058","volume":"69","author":"Z Kozicka","year":"2025","unstructured":"Kozicka Z (2025) Clues for glues: from serendipity to nature\u2019s blueprints in degrader discovery. Essays Biochem 69:379\u2013391. https:\/\/doi.org\/10.1042\/ebc20253058","journal-title":"Essays Biochem"},{"key":"843_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/cells13050426","volume":"13","author":"A Lawer","year":"2024","unstructured":"Lawer A, Schulz L, Sawyer R, Liu X (2024) Harmony of protein tags and chimeric molecules empowers targeted protein ubiquitination and beyond. Cells 13:426. https:\/\/doi.org\/10.3390\/cells13050426","journal-title":"Cells"},{"key":"843_CR49","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/15548627.2024.2396792","volume":"21","author":"A Leytens","year":"2025","unstructured":"Leytens A et al (2025) Targeted proteomics addresses selectivity and complexity of protein degradation by autophagy. Autophagy 21:460\u2013475. https:\/\/doi.org\/10.1080\/15548627.2024.2396792","journal-title":"Autophagy"},{"key":"843_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","volume":"575","author":"Z Li","year":"2019","unstructured":"Li Z et al (2019) Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds. Nature 575:203\u2013209. https:\/\/doi.org\/10.1038\/s41586-019-1722-1","journal-title":"Nature"},{"key":"843_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01765-4","volume":"19","author":"S Li","year":"2025","unstructured":"Li S, Jin Y, Wu H, Yuan H, Zhao J (2025a) Recent advances in targeting protein degradation for tumour immunotherapy. J Hematol Oncol 19:5. https:\/\/doi.org\/10.1186\/s13045-025-01765-4","journal-title":"J Hematol Oncol"},{"key":"843_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123387","volume":"322","author":"Z Li","year":"2025","unstructured":"Li Z et al (2025b) Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy. Biomaterials 322:123387. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123387","journal-title":"Biomaterials"},{"key":"843_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118432","volume":"303","author":"L Lin","year":"2026","unstructured":"Lin L et al (2026) Design of conditional and tumor-activated PROTACs for selective degradation in lung cancer. Eur J Med Chem 303:118432. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118432","journal-title":"Eur J Med Chem"},{"key":"843_CR54","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1039\/d2cc03367d","volume":"58","author":"H Liu","year":"2022","unstructured":"Liu H et al (2022) Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation. Chem Commun (Camb) 58:10072\u201310075. https:\/\/doi.org\/10.1039\/d2cc03367d","journal-title":"Chem Commun (Camb)"},{"key":"843_CR55","doi-asserted-by":"publisher","first-page":"8741","DOI":"10.1021\/acs.nanolett.4c02287","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) Ultrasound-activated PROTAC prodrugs overcome immunosuppression to actuate efficient deep-tissue sono-immunotherapy in orthotopic pancreatic tumor mouse models. Nano Lett 24:8741\u20138751. https:\/\/doi.org\/10.1021\/acs.nanolett.4c02287","journal-title":"Nano Lett"},{"key":"843_CR56","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41565-025-02081-1","volume":"21","author":"Y Liu","year":"2026","unstructured":"Liu Y et al (2026a) Nanoparticle-mediated targeting chimeras transform targeted protein degradation. Nat Nanotechnol 21:176\u2013183. https:\/\/doi.org\/10.1038\/s41565-025-02081-1","journal-title":"Nat Nanotechnol"},{"key":"843_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.cell.2025.12.007","volume":"189","author":"J Liu","year":"2026","unstructured":"Liu J et al (2026b) Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo. Cell 189:1108\u20131123.e1120. https:\/\/doi.org\/10.1016\/j.cell.2025.12.007","journal-title":"Cell"},{"key":"843_CR58","doi-asserted-by":"publisher","unstructured":"Lopez-Girona A et al (2019) CC-90009, a novel cereblon E3 ligase modulator, targets GSPT1 for degradation to induce potent tumoricidal activity against Acute Myeloid Leukemia (AML). Blood 134. https:\/\/doi.org\/10.1182\/blood-2019-127892","DOI":"10.1182\/blood-2019-127892"},{"key":"843_CR59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu G et al (2014) The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343:305\u2013309. https:\/\/doi.org\/10.1126\/science.1244917","journal-title":"Science"},{"key":"843_CR60","doi-asserted-by":"publisher","first-page":"9779","DOI":"10.1021\/jacs.3c14380","volume":"146","author":"B Ma","year":"2024","unstructured":"Ma B et al (2024) Targeted protein O-GlcNAcylation using Bifunctional small molecules. J Am Chem Soc 146:9779\u20139789. https:\/\/doi.org\/10.1021\/jacs.3c14380","journal-title":"J Am Chem Soc"},{"key":"843_CR61","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.chembiol.2025.11.003","volume":"32","author":"AC Mody","year":"2025","unstructured":"Mody AC, Ramirez DH, Woo CM (2025) Targeted protein O-GlcNAc reveals transcriptional functions for O-GlcNAc. Cell Chem Biol 32:1486\u20131502.e1487. https:\/\/doi.org\/10.1016\/j.chembiol.2025.11.003","journal-title":"Cell Chem Biol"},{"key":"843_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-pharmtox-022123-104147","volume":"64","author":"V Oleinikovas","year":"2024","unstructured":"Oleinikovas V, Gainza P, Ryckmans T, Fasching B, Thom\u00e4 NH (2024) From thalidomide to rational molecular glue design for targeted protein degradation. Annu Rev Pharmacol Toxicol 64:291\u2013312. https:\/\/doi.org\/10.1146\/annurev-pharmtox-022123-104147","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"843_CR63","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1096\/fj.13-243535","volume":"28","author":"S Olivier-Van Stichelen","year":"2014","unstructured":"Olivier-Van Stichelen S et al (2014) O-GlcNAcylation stabilizes \u03b2-catenin through direct competition with phosphorylation at threonine 41. FASEB J 28:3325\u20133338. https:\/\/doi.org\/10.1096\/fj.13-243535","journal-title":"FASEB J"},{"key":"843_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501384","volume":"12","author":"M Pan","year":"2025","unstructured":"Pan M et al (2025) Remodeling the physicochemical and pharmacokinetic properties of PROTAC via lipid nanodisks for cancer therapy. Adv Sci 12:e01384. https:\/\/doi.org\/10.1002\/advs.202501384","journal-title":"Adv Sci"},{"key":"843_CR65","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"S-Y Park","year":"2020","unstructured":"Park S-Y, Kim J-S (2020) A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med 52:204\u2013212. https:\/\/doi.org\/10.1038\/s12276-020-0382-4","journal-title":"Exp Mol Med"},{"key":"843_CR66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41392-025-02405-6","volume":"10","author":"B Park","year":"2025","unstructured":"Park B et al (2025) Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy. Signal Transduct Target Ther 10:310. https:\/\/doi.org\/10.1038\/s41392-025-02405-6","journal-title":"Signal Transduct Target Ther"},{"key":"843_CR67","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1021\/acs.biochem.2c00310","volume":"62","author":"RR Paudel","year":"2023","unstructured":"Paudel RR, Lu D, Roy Chowdhury S, Monroy EY, Wang J (2023) Targeted protein degradation via lysosomes. Biochemistry 62:564\u2013579. https:\/\/doi.org\/10.1021\/acs.biochem.2c00310","journal-title":"Biochemistry"},{"issue":"8","key":"843_CR68","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1021\/acscentsci.3c00200","volume":"9","author":"R Pergu","year":"2023","unstructured":"Pergu R et al (2023) Development and applications of chimera platforms for tyrosine phosphorylation. ACS Cent Sci 9(8):1558\u20131566. https:\/\/doi.org\/10.1021\/acscentsci.3c00200","journal-title":"ACS Cent Sci"},{"key":"843_CR69","doi-asserted-by":"publisher","first-page":"25316","DOI":"10.1021\/jacs.5c04275","volume":"147","author":"R Pergu","year":"2025","unstructured":"Pergu R et al (2025) Phosphorylation-inducing molecules for regulating dynamic cellular processes. J Am Chem Soc 147:25316\u201325324. https:\/\/doi.org\/10.1021\/jacs.5c04275","journal-title":"J Am Chem Soc"},{"key":"843_CR70","doi-asserted-by":"publisher","first-page":"22665","DOI":"10.1021\/acs.jmedchem.5c01632","volume":"68","author":"Q Qi","year":"2025","unstructured":"Qi Q, Zhang Z, Ji X, Wang D (2025) Rational design of PROTAC degraders and their spatiotemporal controlled delivery for enhanced tumor penetration and PD-L1 protein degradation. J Med Chem 68:22665\u201322688. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01632","journal-title":"J Med Chem"},{"key":"843_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2026.115821","volume":"232","author":"J Qian","year":"2026","unstructured":"Qian J et al (2026) NanoTAC in targeted protein degradation: intelligent delivery platforms and synergistic therapeutic paradigms. Adv Drug Deliv Rev 232:115821. https:\/\/doi.org\/10.1016\/j.addr.2026.115821","journal-title":"Adv Drug Deliv Rev"},{"key":"843_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109249","volume":"167","author":"MU Rehman","year":"2025","unstructured":"Rehman MU, Wu X, Chen Q, Liu Z, Long S (2025) Lysosome-targeting chimeras: design, mechanisms, and degradation of \u201crogue\u201d proteins. Bioorg Chem 167:109249. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109249","journal-title":"Bioorg Chem"},{"key":"843_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay5064","volume":"6","author":"M Reynders","year":"2020","unstructured":"Reynders M et al (2020) PHOTACs enable optical control of protein degradation. Sci Adv 6:eaay5064. https:\/\/doi.org\/10.1126\/sciadv.aay5064","journal-title":"Sci Adv"},{"key":"843_CR74","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/15548627.2026.2618626","volume":"22","author":"A Rivault","year":"2026","unstructured":"Rivault A et al (2026) Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy. Autophagy 22:881\u2013903. https:\/\/doi.org\/10.1080\/15548627.2026.2618626","journal-title":"Autophagy"},{"key":"843_CR75","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","volume":"62","author":"JM Sasso","year":"2023","unstructured":"Sasso JM et al (2023) Molecular glues: the adhesive connecting targeted protein degradation to the clinic. Biochemistry 62:601\u2013623. https:\/\/doi.org\/10.1021\/acs.biochem.2c00245","journal-title":"Biochemistry"},{"key":"843_CR76","doi-asserted-by":"publisher","first-page":"36352","DOI":"10.1021\/jacs.5c10240","volume":"147","author":"M Serafini","year":"2025","unstructured":"Serafini M et al (2025) Indolequinone-based hypoxia-activated proteolysis targeting chimeras selectively degrade BRD4 in hypoxic cancer cells. J Am Chem Soc 147:36352\u201336364. https:\/\/doi.org\/10.1021\/jacs.5c10240","journal-title":"J Am Chem Soc"},{"key":"843_CR77","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","volume":"7","author":"S Shang","year":"2022","unstructured":"Shang S, Liu J, Hua F (2022) Protein acylation: mechanisms, biological functions and therapeutic targets. Sig Transduct Target Ther 7:396. https:\/\/doi.org\/10.1038\/s41392-022-01245-y","journal-title":"Sig Transduct Target Ther"},{"key":"843_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1505255","volume":"11","author":"J Shi","year":"2024","unstructured":"Shi J et al (2024) Precision-engineered PROTACs minimize off-tissue effects in cancer therapy. Front Mol Biosci 11:1505255. https:\/\/doi.org\/10.3389\/fmolb.2024.1505255","journal-title":"Front Mol Biosci"},{"key":"843_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.tips.2025.10.013","volume":"47","author":"P Shrivastav","year":"2026","unstructured":"Shrivastav P, Singh R, Wiemer AJ (2026) Molecular glues evolve from serendipity to rational design. Trends Pharmacol Sci 47:85\u201399. https:\/\/doi.org\/10.1016\/j.tips.2025.10.013","journal-title":"Trends Pharmacol Sci"},{"key":"843_CR80","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/bs.mie.2023.06.006","volume":"692","author":"NA Springer","year":"2023","unstructured":"Springer NA et al (2023) Methods for the study of ribonuclease targeting chimeras (RiboTACs). Methods Enzymol 692:249\u2013298. https:\/\/doi.org\/10.1016\/bs.mie.2023.06.006","journal-title":"Methods Enzymol"},{"key":"843_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202423057","volume":"64","author":"C Sun","year":"2025","unstructured":"Sun C et al (2025) Enzyme-activated orthogonal proteolysis chimeras for tumor microenvironment-responsive immunomodulation. Angew Chem Int Ed Engl 64:e202423057. https:\/\/doi.org\/10.1002\/anie.202423057","journal-title":"Angew Chem Int Ed Engl"},{"key":"843_CR82","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1021\/jacs.5c11564","volume":"148","author":"F Sun","year":"2026","unstructured":"Sun F et al (2026) A versatile bioorthogonal theranostic platform enables relay activation of tumor cell imaging and targeted protein degradation. J Am Chem Soc 148:258\u2013268. https:\/\/doi.org\/10.1021\/jacs.5c11564","journal-title":"J Am Chem Soc"},{"key":"843_CR83","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1182\/blood.2020008676","volume":"137","author":"C Surka","year":"2021","unstructured":"Surka C et al (2021) CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells. Blood 137:661\u2013677. https:\/\/doi.org\/10.1182\/blood.2020008676","journal-title":"Blood"},{"key":"843_CR84","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","volume":"76","author":"D Takahashi","year":"2019","unstructured":"Takahashi D et al (2019) AUTACs: cargo-specific degraders using selective autophagy. Mol Cell 76:797\u2013810.e710. https:\/\/doi.org\/10.1016\/j.molcel.2019.09.009","journal-title":"Mol Cell"},{"key":"843_CR85","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41580-025-00882-9","volume":"27","author":"T Tiganis","year":"2026","unstructured":"Tiganis T, Tonks NK (2026) Mechanisms, functions and therapeutic targeting of protein tyrosine phosphatases. Nat Rev Mol Cell Biol 27:129\u2013152. https:\/\/doi.org\/10.1038\/s41580-025-00882-9","journal-title":"Nat Rev Mol Cell Biol"},{"key":"843_CR86","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41586-023-06091-8","volume":"618","author":"Y Tong","year":"2023","unstructured":"Tong Y et al (2023) Programming inactive RNA-binding small molecules into bioactive degraders. Nature 618:169\u2013179. https:\/\/doi.org\/10.1038\/s41586-023-06091-8","journal-title":"Nature"},{"key":"843_CR87","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s44321-025-00371-8","volume":"18","author":"B Tong","year":"2026","unstructured":"Tong B et al (2026) Extracellular vesicle-based targeted protein degradation platform for multiple extracellular proteins. EMBO Mol Med 18:759\u2013794. https:\/\/doi.org\/10.1038\/s44321-025-00371-8","journal-title":"EMBO Mol Med"},{"key":"843_CR88","doi-asserted-by":"publisher","first-page":"16700","DOI":"10.1021\/jacs.1c07850","volume":"143","author":"WW Wang","year":"2021","unstructured":"Wang WW et al (2021) Targeted protein acetylation in cells using heterobifunctional molecules. J Am Chem Soc 143:16700\u201316708. https:\/\/doi.org\/10.1021\/jacs.1c07850","journal-title":"J Am Chem Soc"},{"key":"843_CR89","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1021\/acs.nanolett.3c03148","volume":"23","author":"T Wang","year":"2023","unstructured":"Wang T et al (2023) Targeted protein degradation mediated by genetically engineered lysosome-targeting exosomes. Nano Lett 23:9571\u20139578. https:\/\/doi.org\/10.1021\/acs.nanolett.3c03148","journal-title":"Nano Lett"},{"key":"843_CR90","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-024-02024-9","volume":"23","author":"C Wang","year":"2024","unstructured":"Wang C, Zhang Y, Chen W, Wu Y, Xing D (2024) New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer 23:110. https:\/\/doi.org\/10.1186\/s12943-024-02024-9","journal-title":"Mol Cancer"},{"key":"843_CR91","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/acs.accounts.5c00326","volume":"58","author":"WW Wang","year":"2025","unstructured":"Wang WW, Singha Roy SJ, Parker CG (2025a) Targeted protein acetylation through chemically induced proximity. Acc Chem Res 58:2695\u20132707. https:\/\/doi.org\/10.1021\/acs.accounts.5c00326","journal-title":"Acc Chem Res"},{"key":"843_CR92","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1007\/s11426-025-3083-4","volume":"68","author":"N Wang","year":"2025","unstructured":"Wang N et al (2025b) Spatiotemporally controlled protein degradation via NIR-activatable PROTAC platform. Sci China Chem 68:6621\u20136627. https:\/\/doi.org\/10.1007\/s11426-025-3083-4","journal-title":"Sci China Chem"},{"key":"843_CR93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41573-023-00833-z","volume":"23","author":"JA Wells","year":"2024","unstructured":"Wells JA, Kumru K (2024) Extracellular targeted protein degradation: an emerging modality for drug discovery. Nat Rev Drug Discov 23:126\u2013140. https:\/\/doi.org\/10.1038\/s41573-023-00833-z","journal-title":"Nat Rev Drug Discov"},{"key":"843_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116062","volume":"265","author":"W Weng","year":"2024","unstructured":"Weng W, Xue G, Pan Z (2024) Development of visible-light-activatable photocaged PROTACs. Eur J Med Chem 265:116062. https:\/\/doi.org\/10.1016\/j.ejmech.2023.116062","journal-title":"Eur J Med Chem"},{"key":"843_CR95","doi-asserted-by":"publisher","first-page":"11580","DOI":"10.1021\/acs.jmedchem.4c00723","volume":"67","author":"Y Xiao","year":"2024","unstructured":"Xiao Y et al (2024) Targeted protein degradation: current and emerging approaches for E3 ligase deconvolution. J Med Chem 67:11580\u201311596. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00723","journal-title":"J Med Chem"},{"key":"843_CR96","doi-asserted-by":"publisher","first-page":"18370","DOI":"10.1021\/jacs.9b06422","volume":"141","author":"G Xue","year":"2019","unstructured":"Xue G, Wang K, Zhou D, Zhong H, Pan Z (2019) Light-induced protein degradation with photocaged PROTACs. J Am Chem Soc 141:18370\u201318374. https:\/\/doi.org\/10.1021\/jacs.9b06422","journal-title":"J Am Chem Soc"},{"key":"843_CR97","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1021\/acs.jmedchem.9b01167","volume":"63","author":"S Yamazoe","year":"2020","unstructured":"Yamazoe S et al (2020) Heterobifunctional molecules induce Dephosphorylation of kinases\u2013a proof of concept study. J Med Chem 63:2807\u20132813. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01167","journal-title":"J Med Chem"},{"key":"843_CR98","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/jacs.2c10177","volume":"145","author":"C Yang","year":"2023","unstructured":"Yang C, Yang Y, Li Y, Ni Q, Li J (2023) Radiotherapy-triggered proteolysis targeting chimera prodrug activation in tumors. J Am Chem Soc 145:385\u2013391. https:\/\/doi.org\/10.1021\/jacs.2c10177","journal-title":"J Am Chem Soc"},{"key":"843_CR99","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-024-01983-1","volume":"9","author":"L Yang","year":"2024","unstructured":"Yang L et al (2024) Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy. Signal Transduct Target Ther 9:275. https:\/\/doi.org\/10.1038\/s41392-024-01983-1","journal-title":"Signal Transduct Target Ther"},{"key":"843_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202505105","volume":"15","author":"Y Yang","year":"2026","unstructured":"Yang Y et al (2026) Enzyme-instructed Nanofibrous assemblies enable targeted PROTAC release for cancer therapy. Adv Healthc Mater 15:e05105. https:\/\/doi.org\/10.1002\/adhm.202505105","journal-title":"Adv Healthc Mater"},{"key":"843_CR101","doi-asserted-by":"publisher","first-page":"18208","DOI":"10.1021\/jacs.5c04857","volume":"147","author":"Q Yao","year":"2025","unstructured":"Yao Q et al (2025) Reactive oxygen species-instructed supramolecular assemblies enable bioorthogonally Activatable protein degradation for pancreatic cancer. J Am Chem Soc 147:18208\u201318218. https:\/\/doi.org\/10.1021\/jacs.5c04857","journal-title":"J Am Chem Soc"},{"key":"843_CR102","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/acscentsci.1c00146","volume":"7","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Teng P, Montgomery NT, Li X, Tang W (2021) Development of triantennary N-Acetylgalactosamine conjugates as degraders for extracellular proteins. ACS Cent Sci 7:499\u2013506. https:\/\/doi.org\/10.1021\/acscentsci.1c00146","journal-title":"ACS Cent Sci"},{"key":"843_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2025.102778","volume":"6","author":"X Zhou","year":"2025","unstructured":"Zhou X, Xiao Y, Gao Y (2025a) Challenges and opportunities for lysosome-targeting chimeras. Cell Rep Phys Sci 6:102778. https:\/\/doi.org\/10.1016\/j.xcrp.2025.102778","journal-title":"Cell Rep Phys Sci"},{"key":"843_CR104","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.3390\/ijms26146576","volume":"26","author":"Z Zhou","year":"2025","unstructured":"Zhou Z et al (2025b) Targeted degradation technologies utilizing autophagy. Int J Mol Sci 26:6576. https:\/\/doi.org\/10.3390\/ijms26146576","journal-title":"Int J Mol Sci"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2026_843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:47:48Z","timestamp":1791928068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2026_843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":104,"URL":"https:\/\/doi.org\/10.1007\/164_2026_843","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"14 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}